Nasdaq: PYXS
Pyxis Oncology insiders
The officers, directors and 10% owners of Pyxis Oncology, Inc. who hold the most stock, valued at the live PYXS price.
$1.68
PYXS today +$270K (+19.15%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their PYXS stock
- $26.5M
- Market value
- $201M
- Held by ranked insiders
- 13.2%
Insiders by value of PYXS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Pfizer INC | 10% owner | 7,032,770 | $11.8M | 5.88% | Corporate |
| 2 | Barclays PLC | 10% owner | 3,477,975 | $5.8M | 2.91% | Corporate |
| 3 | Pamela Ann Connealy | CFO & COO | 3,425,179 | $5.8M | 2.86% | 12452nd |
| 4 | Mark Chin | Insider | 1,812,592 | $3.0M | 1.52% | 1385th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Pyxis Oncology; see each profile for the filing.